Suppression of tissue factor expression, cofactor activity, and metastatic potential of murine melanoma cells by the N-terminal domain of adenovirus E1A 12S protein.
Tissue factor, the cellular initiator of blood coagulation, has been implicated as a determinant of metastatic potential in human melanoma cells. Here, we report that differential expression of tissue factor in murine melanoma cell lines of known metastatic behavior is mediated by AP-1-dependent and 12S E1A oncoprotein-repressible gene transcription. When compared to weakly metastatic C10 cells, highly metastatic M4 cells possessed elevated levels of tissue factor cofactor activity, transfected promoter activity, and heterodimeric AP-1 DNA-binding complexes containing Fra-1. Transient co-expression of the adenovirus E1A 12S oncoprotein strongly repressed transcription of an AP-1-driven tissue factor reporter gene indicating the additional requirement of N-terminal E1A-interacting coactivators. Stable expression of E1A mutants defective in CBP/p300-binding failed to suppress tissue factor expression and experimental metastasis by M4 cells while clones expressing wild type E1A exhibited greatly reduced tissue factor cofactor activity and metastatic potential in vivo. Overexpression of functional tissue factor in cells containing wild type E1A failed to restore the highly metastatic M4 phenotype suggesting that additional E1A-responsive and CBP/p300-dependent genes are required to facilitate metastasis of murine melanoma cells demonstrating high tissue factor expression and cofactor activity.
Voigtländer
Constanze
C
Department of Biochemistry and Molecular Biology, Program in Tumor Biology, Mayo Clinic/Foundation, Rochester, Minnesota 55905, USA.
Rand
Arlymae
A
Liu
Su-Ling
SL
Wilson
Timothy J
TJ
Pittelkow
Mark R
MR
Getz
Michael J
MJ
Kelm
Robert J
RJ
D017500:Adenovirus E1A Proteins / Q000494:pharmacology*; D000818:Animals; D050881:E1A-Associated p300 Protein; D015972:Gene Expression Regulation, Neoplastic / Q000187:drug effects*; D019337:Hematologic Neoplasms / Q000473:pathology; D008175:Lung Neoplasms / Q000556:secondary; D008545:Melanoma / Q000473:pathology / Q000556:secondary*; D051379:Mice; D016513:Mice, SCID; D008962:Models, Theoretical; D009362:Neoplasm Metastasis; D009687:Nuclear Proteins / Q000378:metabolism; D011401:Promoter Regions, Genetic / Q000187:drug effects; D017434:Protein Structure, Tertiary / Q000502:physiology; D016760:Proto-Oncogene Proteins c-fos / Q000378:metabolism; D013925:Thromboplastin / Q000096:biosynthesis* / Q000235:genetics; D015534:Trans-Activators / Q000378:metabolism; D018808:Transcription Factor AP-1 / Q000378:metabolism; D014158:Transcription, Genetic / Q000187:drug effects; D014407:Tumor Cells, Cultured; D000099169:Fos-Related Antigen 1
D017500:Adenovirus E1A Proteins; D050881:E1A-Associated p300 Protein; D009687:Nuclear Proteins; D016760:Proto-Oncogene Proteins c-fos; D013925:Thromboplastin; D015534:Trans-Activators; D018808:Transcription Factor AP-1; D000099169:Fos-Related Antigen 1; C494361:Ep300 protein, mouse